# PHARMACYTE BIOTECH INC COM NEW Stock

PHARMACYTE BIOTECH INC COM NEW Stock is a security (CUSIP 71715X104) tracked across SEC portfolio filings. 4 institutional managers reported $7 on Form 13F as of 2026-06-30.

## Summary

- Issuer: PHARMACYTE BIOTECH INC COM NEW
- Class: Stock
- CUSIP: 71715X104
- 13F holders: 4
- 13F value: $7
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [CoreCap Advisors, LLC](https://search.stillhousedata.com/firm/158819) | SOUTHFIELD, MI | $3 | 4 |
| [HARBOUR INVESTMENTS, INC.](https://search.stillhousedata.com/firm/19258) | MADISON, WI | $2 | 3 |
| [CALDWELL SUTTER CAPITAL, INC.](https://search.stillhousedata.com/firm/10489) | SAUSALITO, CA | $2 | 2 |
| HUNTINGTON NATIONAL BANK | COLUMBUS, OH | — | 1 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/71715X104.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.